Applying Ethics and Integrity to Human Research
IntegReview reviews the following types of research: Phase I-IV drug/biomedical, medical device, social and behavioral, Investigator-sponsored, single and multiple investigator as well as research conducted in academic and hospital settings, expedited review for research that qualifies, expedited review of additional Investigators, research determined to be exempt, research conducted in Latin America and Canada.
facebook
IntegReview Ethical Review Board
3001 S. Lamar Blvd., Suite 210
Austin, TX 78704
Phone: 512-326-3001
Fax: 512-697-0085
Email:

Principal Investigator

In an effort to enhance IntegReview’s Human Research Protection Program (HRPP), we would like to provide investigators with the responsibilities we feel are necessary to protect the welfare and safety of research participants while conducting research.

Please view the links below to obtain information on investigator responsibilities, IntegReview reporting requirements, investigator training, and other links we feel will be helpful regarding federal regulations, guidance on conducting research, etc.

Investigator Responsibilities
IntegReview Reporting Requirements
Training Links
Form FDA 1572
Regulation and Guidance Documents
Adobe Acrobat Reader